EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

ATP1A3 Variants, Variably Penetrant Short QT Intervals, and Lethal Ventricular Arrhythmias

Mary E Moya-Mendez, Minu-Tshyeto Bidzimou, Padmapriya Muralidharan, Zhushan Zhang, Jordan E Ezekian, Robin M Perelli, Lauren E Parker, Lyndsey Prange, April Boggs, Jeffrey J Kim, Taylor S Howard, Tarah A Word und 36 weitere

JAMA Pediatrics · 01.05.2025 · 179 (5) · 529

DOI: 10.1001/jamapediatrics.2024.6832 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JAMA Pediatrics, erschienen am 01.05.2025. Verfasst von Mary E Moya-Mendez und 47 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Pediatric Cardiology, Duke University School of Medicine, Durham, North Carolina. Hauptthemen laut MEDLINE: Sodium-Potassium-Exchanging ATPase, Arrhythmias, Cardiac. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Alternating hemiplegia of childhood (AHC) is a disorder that can result from pathogenic variants in ATP1A3 -encoded sodium-potassium adenosine triphosphatase alpha 3 (ATP1A3). While AHC is primarily a neurologic disease, some individuals experience sudden unexplained death (SUD) potentially associated with cardiac arrhythmias.

Objective

To determine the impact of ATP1A3 variants on cardiac electrophysiology and whether lethal ventricular arrhythmias are associated with SUD in patients with AHC. Design, Setting, and Participants In this international, multicenter case-control study from 12 centers across 10 countries, patients with AHC were grouped by ATP1A3 variant status (positive vs negative) and into subgroups with the most common AHC variants (D801N, E815K, G947R, and other). A healthy control cohort was established for comparison. Blinded, manual measurements of QT intervals and corrected QT interval (QTc) were performed independently by 2 pediatric cardiac electrophysiologists. Induced pluripotent stem cell cardiomyocytes were derived from patients with AHC who were positive for the D801N variant of ATP1A3 (iPSC-CM D801N cells). Data analysis was performed from April to June 2022. Exposure Presence of ATP1A3 variant. Main Outcomes and Measures The primary outcome was QTc. Outcomes, including survival, were abstracted and variants were mapped on cryogenic electron microscopy structure maps. iPSC-CM D801N cells were used to validate ventricular repolarization and arrhythmic susceptibility in vitro.

Results

Among the 222 individuals included (148 with AHC and 74 control), the mean (SD) age at diagnostic electrocardiography was 11.0 (9.4) years and 119 (54%) were female. The cohort with AHC consisted of 148 largely unrelated probands (mean [SD] age at diagnostic electrocardiography, 11.5 [10.5] years). Of these, 123 individuals were ATP1A3 genotype positive, including 35 (28%) with the D801N variant, 21 (17%) with the E815K variant, 8 (7%) with the G947R variant, and 8 (7%) with a loss-of-function variant. Probands with the D801N variant had shorter mean (SD) QTcs (381.8 [36.6] milliseconds; 24 [69%] with QTc <370 milliseconds) compared with those who had the E815K variant (393.6 [43.1] milliseconds; P = .001; 4 [19%] with QTC <370 milliseconds), the G947R variant (388.4 [26.5] milliseconds; P = .02; 1 [13%] with QTc <370 milliseconds), a loss-of-function variant (403.0 [33.5] milliseconds; P < .001; 1 [13%] with QTc <370 milliseconds), all other variants (387.8 [37.1] milliseconds; P < .001; 44 [86%] with QTc <370 milliseconds), and healthy controls (415.4 [21.0] milliseconds; P < .001; 0 with QTc <370 milliseconds). Three D801N-positive individuals had a major cardiac event, compared with 0 major cardiac events in all other individuals ( P = .02). The D801N variant and 4 rare variants (D805N, P323S, S772R, and C333F) found in individuals with the shortest QTcs localized to the potassium-binding domain of ATP1A3. IPSC-CM D801N lines demonstrated shortened action potential duration, higher mean diastolic potential, and delayed afterdepolarizations compared with controls. Conclusions and Relevance Nearly 70% of individuals with D801N variants of ATP1A3 had short QTcs (<370 milliseconds), with an association between ventricular arrhythmias and cardiac arrest. This may underlie the SUD etiology in AHC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sodium-Potassium-Exchanging ATPaseArrhythmias, CardiacHumansFemaleMaleCase-Control StudiesChildElectrocardiographyAdolescentChild, PreschoolDeath, Sudden, CardiacGenetic VariationHemiplegia

Substanzen

Sodium-Potassium-Exchanging ATPaseATP1A3 protein, human

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Pediatric Cardiology, Duke University School of Medicine, Durham, North Carolina.
  • Division of Pediatric Cardiology, Department of Pediatrics, University of Texas Southwestern, Dallas.
  • Department of Cell Biology, Duke University School of Medicine, Durham, North Carolina.
  • Department of Pediatrics, Division of Neurology, Duke University School of Medicine, Durham, North Carolina.
  • Department of Pediatrics, Section of Cardiology, Baylor College of Medicine, Houston, Texas.
  • Cardiovascular Research Institute, Baylor College of Medicine, Houston, Texas.

Förderung

  • NINDS NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Moya-Mendez, M. E., Bidzimou, M. T., Muralidharan, P., Zhang, Z., Ezekian, J. E., Perelli, R. M., Parker, L. E., Prange, L., Boggs, A., Kim, J. J., Howard, T. S., Word, T. A., Wehrens, X. H. T., Reyes Valenzuela, G., Caraballo, R., Garone, G., Vigevano, F., Weckhuysen, S., Millevert, C., …, & Landstrom, A. P. (2025). ATP1A3 Variants, Variably Penetrant Short QT Intervals, and Lethal Ventricular Arrhythmias. JAMA Pediatrics, 179(5), 529. https://doi.org/10.1001/jamapediatrics.2024.6832

Vancouver

Moya-Mendez ME, Bidzimou MT, Muralidharan P, Zhang Z, Ezekian JE, Perelli RM, et al. ATP1A3 Variants, Variably Penetrant Short QT Intervals, and Lethal Ventricular Arrhythmias. JAMA Pediatrics. 2025;179(5):529. doi:10.1001/jamapediatrics.2024.6832

BibTeX
@article{MoyaMendez2025,
  author = {Moya-Mendez, Mary E and Bidzimou, Minu-Tshyeto and Muralidharan, Padmapriya and Zhang, Zhushan and Ezekian, Jordan E and Perelli, Robin M and Parker, Lauren E and Prange, Lyndsey and Boggs, April and Kim, Jeffrey J and Howard, Taylor S and Word, Tarah A and Wehrens, Xander H T and Reyes Valenzuela, Gabriela and Caraballo, Roberto and Garone, Giacomo and Vigevano, Federico and Weckhuysen, Sarah and Millevert, Charissa and Troncoso, Monica and Matamala, Mario and Balestrini, Simona and Sisodiya, Sanjay M and Poole, Josephine and Zucca, Claudio and Panagiotakaki, Eleni and Papadopoulou, Maria T and Tchaicha, Sébile and Zawadzka, Marta and Mazurkiewicz-Beldzinska, Maria and Fons, Carmen and Anticona, Jennifer and De Grandis, Elisa and Cordani, Ramona and Pisciotta, Livia and Groppa, Sergiu and Paryjas, Sandra and Ragona, Francesca and Mangia, Elena and Granata, Tiziana and Megvinov, Andrey and Pavlicek, Mirjana and Ess, Kevin and Simmons, Christine Q and George, Alfred L and Vavassori, Rosaria and Mikati, Mohamad A and Landstrom, Andrew P},
  title = {ATP1A3 Variants, Variably Penetrant Short QT Intervals, and Lethal Ventricular Arrhythmias},
  journal = {JAMA Pediatrics},
  year = {2025},
  volume = {179},
  number = {5},
  pages = {529},
  doi = {10.1001/jamapediatrics.2024.6832}
}
Kostenlos starten →